Cyclooxygenase mediates cardioprotection of angiotensin-(1-7) against ischemia/reperfusion-induced injury through the inhibition of oxidative stress

Mol Med Rep. 2011 Nov-Dec;4(6):1145-50. doi: 10.3892/mmr.2011.570. Epub 2011 Aug 23.

Abstract

Angiotensin (Ang)-(1-7) exhibits cardioprotective effects in myocardial ischemia reperfusion (I/‌R)-induced injury. However, the roles of oxidation and cyclooxygenase (COX) in the cardioprotection of Ang-(1-7) remain unclear. This study was conducted to investigate whether oxidation and COX were involved in the cardioprotection of Ang-(1-7) against I/‌R-induced injury in isolated rat hearts. The hearts were subjected to 15 min regional ischemia followed by 30 min reperfusion. Myocardial I/‌R treatment induced significant cardiac dysfunction, including ventricular arrhythmia (VA) and a reduction of left ventricular systolic pressure (LVSP), cardiomyocyte apoptosis and oxidative stress, manifesting as an increase in malondialdehyde (MDA) production and a decrease in superoxide dismutase (SOD) activity. Pretreatment of the hearts with 1.0 nmol/‌l Ang-(1-7) for 30 min prior to ischemia considerably attenuated I/‌R-induced VA, apoptosis and MDA production, and enhanced LVSP and SOD activity. These cardioprotective effects of Ang-(1-7) were antagonized by the intraperitoneal injection of 5 mg/‌kg body weight indomethacin (IDM, a COX inhibitor), presenting as an enhancement of VA, apoptosis and MDA production as well as a reduction of LVSP and SOD activity. In conclusion, COX mediated Ang-(1-7)-induced cardioprotection via its antioxidative mechanism.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin I / pharmacology*
  • Animals
  • Apoptosis / drug effects
  • Arrhythmias, Cardiac / prevention & control
  • Blood Pressure / physiology
  • Cardiotonic Agents / pharmacology*
  • Cyclooxygenase Inhibitors / pharmacology
  • Indomethacin / pharmacology
  • Male
  • Malondialdehyde / metabolism
  • Myocardial Reperfusion Injury / metabolism
  • Myocardial Reperfusion Injury / prevention & control*
  • Oxidative Stress / drug effects*
  • Peptide Fragments / pharmacology*
  • Prostaglandin-Endoperoxide Synthases / metabolism*
  • Rats
  • Superoxide Dismutase / metabolism
  • Ventricular Function / physiology

Substances

  • Cardiotonic Agents
  • Cyclooxygenase Inhibitors
  • Peptide Fragments
  • Malondialdehyde
  • Angiotensin I
  • Prostaglandin-Endoperoxide Synthases
  • Superoxide Dismutase
  • angiotensin I (1-7)
  • Indomethacin